en · de · es · pt
thymosin-alpha-1-notes.peptides3626.com › Guide › Research History And Clinical Assessment — Reference Sheet

Research History And Clinical Assessment — Reference Sheet

By Editorial Desk · published 2025-12-26 · last reviewed 2026-02-15 · Guide

prothymosin alpha is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.

Updated 2026-02-15. Numbers and descriptions here follow the published literature rather than marketing material.

Research History and Clinical Assessment

Thymosin alpha 1 was identified in 1977 as a component of thymosin fraction 5, a heterogeneous preparation used in early studies of thymic function. Investigators purified the active material and determined its amino acid sequence, which enabled chemical synthesis. Work in the following decades concentrated on T-cell maturation and immune reconstitution in animals and small human cohorts. Early preparations varied in composition, so results from that period are difficult to compare with studies using defined synthetic peptide.

Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Findings across trials are mixed; some report changes in selected immune markers, while others find no clear clinical benefit. Many studies are small and define outcomes differently, which limits comparison. Regulatory approval is confined to a few countries, and the compound is not an approved drug in the United States or most of Europe.

Overall evidence quality varies considerably. A large share of published reports come from single centers, rely on surrogate immunological markers, or lack adequate control groups. Systematic reviews have highlighted this heterogeneity as a barrier to pooling results. Open questions include which patients, if any, might benefit, what treatment duration is appropriate, and whether any effect is independent of standard care. The peptide is often described as an immune modulator rather than a therapy for one disease, which complicates confirmatory trial design.

Identity and Molecular Background

Several names appear in the literature for this peptide, including thymalfasin and the abbreviation T-alpha-1. Naming conventions differ among research articles, regulatory documents, and supplier catalogs, which complicates literature searches. Both synthetic and recombinant production routes yield a peptide with the same 28-residue sequence as the thymic isolate. Because the thymosin label also covers unrelated peptides, sources should be compared by sequence rather than by name alone.

The peptide occurs naturally in thymic tissue and has been detected in serum and other biological fluids. Reported concentrations are low, and reliable measurement generally requires immunoassay or mass spectrometry with an enrichment step. It is released from a larger precursor, prothymosin alpha, by proteolytic cleavage, although the enzymes involved are not fully characterized. Whether circulating levels reflect thymic output specifically remains an open question.

Thymosin-alpha-1 at a glance

PropertyValueNotes
First described1977Reported as a component of thymosin fraction 5
Sequence length28 amino acidsN-terminal residue is acetylated
Net charge at neutral pHNegativeReflects a high proportion of acidic residues
Principal studied usesChronic hepatitis B and vaccine adjuvantResearch uses outnumber approved indications
Regulatory statusApproved in a limited number of countriesNot approved in the United States or most of Europe

Handling, Storage, and Analytical Verification

Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, which separates the target peptide from truncated or chemically modified byproducts. Mass spectrometry confirms the expected molecular mass and can indicate acetylation state or sequence errors. Amino acid analysis and peptide mapping supply complementary sequence-level information, while endotoxin testing is relevant for preparations intended for cell or animal work. Purity figures reported by suppliers refer to the method used and are not directly comparable across laboratories unless conditions are stated.

Lyophilized material is typically treated as a hygroscopic solid that should be brought to room temperature before the container is opened, which limits condensation on the powder. Reconstitution is commonly done with sterile water or a buffered diluent, and gentle mixing is preferred over vigorous agitation to reduce foaming and surface adsorption. Because peptides can bind to plastic and glass, diluents containing a small amount of carrier protein are sometimes used in laboratory work. Working solutions are generally aliquoted and prepared fresh rather than subjected to repeated freezing and thawing.

Stability depends on temperature, pH, and the number of freeze-thaw events the sample has experienced. Freeze-dried material is commonly held at -20 °C or colder, while reconstituted liquid is kept cold and used within a short window. Extreme pH and prolonged light exposure can promote deamidation, oxidation, or aggregation, particularly at asparagine and methionine positions. Adsorption to container walls can lower the measured concentration of a dilute solution even when the peptide molecules themselves remain intact.

Related pages on this site

Background and Biological Role

The name itself causes confusion, because several unrelated thymic peptides share the thymosin label. Thymosin beta-4, for example, is a different molecule with different functions. Naming conventions in the literature also mix descriptive research terms with assigned nonproprietary names, so a reader should confirm which entity a given paper addresses. Clarifying that point is usually the first step in interpreting any claim about this peptide.

Thymosin alpha-1 is a short peptide of 28 amino acid residues first described in the 1970s as a component of thymic extracts. Its N-terminal residue carries an acetyl group, and the sequence is highly conserved across mammalian species. The peptide is not encoded as a standalone gene product; it is released by proteolytic cleavage from the N-terminus of prothymosin alpha, a larger acidic nuclear protein. That precursor relationship places it within a broader family of thymic and immune-associated peptides that have been studied for decades.

Background and Molecular Profile

The peptide is generated in cells by cleavage of prothymosin alpha, a larger acidic protein encoded by the PTMA gene. Prothymosin alpha is expressed in many tissues, not only in the thymus, and its functions include nuclear roles in chromatin-related processes. The 28-residue fragment corresponds to the N-terminal portion of that precursor. How the cleavage occurs and how the fragment's concentration is regulated remain open questions; circulating amounts are small and difficult to measure reliably with routine assays.

Thymosin alpha 1 is a short peptide first isolated from bovine thymus tissue in the early 1970s during fractionation work aimed at identifying factors that influence T cell development. It belongs to a family of acidic thymic peptides, and the original preparations contained several components that were later separated by chromatography. The compound is now produced synthetically rather than extracted from tissue, which removes batch variability tied to animal sourcing. Researchers describe it as an immunomodulatory peptide because laboratory studies show effects on several cell types of the innate and adaptive immune systems.

The molecule consists of 28 amino acid residues with an acetyl group attached to the N-terminal serine. Its sequence is acidic overall, with several glutamic and aspartic acid residues distributed along the chain and no cysteine, so disulfide bridges do not form. The peptide carries a net negative charge at physiological pH. Because the N-terminus is blocked, the intact molecule resists degradation by many aminopeptidases, which contributes to its stability in biological fluids.

Background from the literature

=== Treatment of type 2 diabetes === They are widely used as antidiabetic drugs in the management of diabetes mellitus type 2. They act by increasing secretion of insulin from the beta cells in the pancreas. Sulfonylureas are ineffective where there is absolute deficiency of insulin production such as in type 1 diabetes or post-pancreatectomy. Sulfonylureas can be used to treat some types of neonatal diabetes. Historically, people with hyperglycemia and low blood insulin levels were diagnosed with type 1 diabetes by default, but it has been found that patients who receive this diagnosis before 6 months of age are often candidates for receiving sulfonylureas rather than insulin throughout life. A 2011 Cochrane systematic review evaluated the effects on treatment of Latent Autoimmune Diabetes in Adults (LADA) and found that Sulfonylureas did not improve metabolic control of glucose at 3 and 12 months, even worsening HbA1c levels in some cases, when compared to insulin. The same review did not find improvement of fasting C-peptide following treatment with sulfonylurea. Still, it is important to highlight that the studies available to be included in this review presented considerable flaws in quality and design. While prior sulfonylureas were associated with worse outcomes, newer agents do not appear to increase the risk of death, heart attacks, or strokes.

In April 2012, the Xinjiang Border Defense Corps Female Special Service team (新疆公安边防总队女子特勤分队) was founded. In March 2015 it was renamed to the "Snowy Eagle Female Special Service team" (雪鹰女子特勤分队) at the Xinjiang Border Corps Training Base. At its founding in 2012, it only had 6 members, and by March 2015 it had 34 members. It assisted in security at the China Eurasia Expo multiple times. The Shenzhen Border Defense Detachment operated the Maritime Special Service Team (Nicknamed "Maritime Jiaolongs"), a police tactical unit which is dedicated to maritime anti-terrorism, search and rescue, combat diving and VBSS.

== Interaction with other cells == The phenotypes of dermal macrophages can be affected by the cytokines expressed by other immune cells. They can obtain a pro-inflammatory (M1) or anti-inflammatory (M2) phenotype. Cytokines such as IFN-γ skew dermal macrophages to the M1 phenotype, while IL-4 and IL-13 skew them to the M2 phenotype. Phenotype acquisition is the hallmark of macrophage activation. Activation of dermal macrophages can also be achieved by direct contact. Ligands such as CD4 on T cells can trigger dermal macrophages to release pro-inflammatory cytokines during inflammation. This process also preserves the population of circulating monocytes and thereby increases their activity. Dermal macrophages are involved in the adaptive immune system due to their antigen-presenting ability. Dermal macrophages' expression of cell markers like CD11b, F4/80 and MHC II indicate their participation in the MHC II antigen-presenting pathway. However, the MHC II expression is low compared to Langerhans cells, rendering dermal macrophages minor contributors to antigen presentation.

=== Army service === In the U.S. Army, Jones took part in World War I in an all-Black unit until his mechanical skills were spotted, and he was promoted to sergeant working as an electrician and even teaching other soldiers. Jones performed the wiring necessary to equip his camp with electricity, telegraph, and telephone services.

Sources: en.wikipedia.org

Further detail

=== 21st century === The West China University of Medical Sciences merged with Sichuan University in 2000. The dental school and hospital adopted their current Sichuan University names in 2001, becoming the West China School of Stomatology and the West China Hospital of Stomatology. A new clinical building was completed in 2009, followed by a dedicated research building in 2010. During the 2000s and 2010s, the institution also expanded its national research infrastructure, including laboratories in oral diseases, regenerative medicine and clinical research. In 2020, the National Health Commission entrusted the institution to serve as one of the three National Centers for Stomatology (国家口腔医学中心) in the country. The stomatology national-center system was designed to concentrate expertise in the diagnosis and treatment of complex oral diseases, professional training, clinical research, standards development, and quality control.

RCO2H + R'2NH → RCO−2 + R'2NH+2 RCO−2 + R'2NH+2 → RC(O)NR'2 + H2O Esters are far superior substrates relative to carboxylic acids. Further "activating" both acid chlorides (Schotten-Baumann reaction) and anhydrides (Lumière–Barbier method) react with amines to give amides:

The TNXB gene has an associated pseudogene, TNXA. Both TNXA and TNXB genes are located within the RCCX cluster, which consists of a series of modules with genes close to each other: winged helix repair factor 1 (WHR1), complement 4 (C4), steroid 21-hydroxylase (CYP21), and tenascin-X (TNX). In a monomodular structure of the RCCX cluster, all of the genes are functional, i.e. protein-coding, but if there are two or more modules within the cluster, there is only one copy of each functional gene rest being non-coding pseudogenes with the exception of the C4 gene which always has active copies. For example, in a bimodular configuration most common among Europeans, the cluster consists of the following genes: WHR1-C4A-CYP21A1P-TNXA-STK19B-C4B-CYP21A2-TNXB. As such, TNXA is a duplicated copy of TNXB, but is incomplete, therefore, TNXA a pseudogene that is transcribed but does not encode a protein. The presence of the pseudogene is a consequence of MHC class III locus duplication during evolution. Strong 3' homology between TNXB and TNXA can provoke genetic recombination between the two loci, thus leading to the apparition of TNXA/TNXB chimera.

Concetta Hospital is a general hospital based in Kinnigoli, Dakshina Kannada District Karnataka, India. Concetta Hospital, which was started in 1958 with just 12 beds has now grown into a large Hospital having 65 beds with modern equipment and medical facilities available for the patients of the rural area. Sanjivini, an outreach unit of the hospital, provides a variety of health services to the poor and needy people of Kinnigoli and surrounding villages. Services available at Concetta Hospital include:

He uses his new batteries to enlarge himself, but is deleted by the Deka Wing Cannon. Terry X is voiced by Kenji Hamada (浜田 賢二, Hamada Kenji). Kulernian Jellyfis (クラーン星人ジェリフィス, Kurān Seijin Jerifisu): A non-humanoid jellyfish-themed criminal from Planet Kulern who can take over human beings' nervous systems, which is forbidden by space law. He controls Ban, but Tetsu uses his own Super Electro Fist to briefly kill him, forcing Jellyfis off before Tetsu revives Ban with his Electro Fist technique. Jellyfis pilots the Kaijuki Million Missile in retaliation, but is deleted by Super Dekaranger Robo, which Agent Abrella takes advantage of to storm the Deka Base. Jellyfis is voiced by Kōzō Shioya (塩屋 浩三, Shioya Kōzō). Gimonian Angorl (ギモ星人アンゴール, Gimo Seijin Angōru): An anglerfish-themed criminal from Planet Gimo whom Agent Abrella broke out of prison and equipped with a Hyper Muscle Gear to assist in attacking the Deka Base via his personal Kaijuki, Abtrex, only to be deleted by the Deka Wing Cannon and Deka Bike Robo. Angorl is voiced by Keiichi Sonobe (園部 啓一, Sonobe Keiichi). Gedonian Uniga (ゲド星人ウニーガ, Gedo Seijin Unīga): A sea urchin–themed criminal from Planet Gedo and the inspiration behind the Igaroids whom Agent Abrella broke out of prison and equipped with a Hyper Muscle Gear to assist in attacking the Deka Base, only to be deleted by the Dekarangers. Uniga is voiced by Kazuya Nakai.

Sources: en.wikipedia.org

Supporting material

==== Plans to sell TikTok's US operations ==== Since at least 2020, following calls to ban TikTok in the country, the Committee on Foreign Investment in the United States (CFIUS) has been investigating the company's 2017 merger with Musical.ly but has not finalized any of its negotiations with TikTok, such as the Project Texas proposal, waiting instead for Congress to act. In January 2025, Chinese officials began preliminary talks about potentially selling TikTok's US operations to Elon Musk if the app faced an impending ban due to national security concerns. While Beijing preferred TikTok remain under ByteDance's control, the sale could happen through a competitive process or with US government involvement. One possibility involved Musk's platform, X, taking over TikTok's US business. The move came ahead of a Supreme Court case that upheld the constitutionality of a law that would force a sale or ban of TikTok in the US by 19 January 2025, due to national security concerns regarding its ties to China. Other potential buyers included Project Liberty's "The People's Bid For TikTok" consortium of Frank McCourt with Kevin O'Leary, Steven Mnuchin, and Bobby Kotick, and an investor consortium led by Employer.com founder Jesse Tinsley that included Roblox CEO David Baszucki and YouTuber MrBeast and claimed to have secured over US$20 billion in commitments. The seriousness of these potential buyers was unclear. The day before the impending ban, California-based conversational search engine company Perplexity AI submitted a bid for a merger with TikTok US.

=== Category:EC 1.21 (act on X-H and Y-H to form an X-Y bond) === Category:EC 1.21.1 Iodotyrosine deiodinase EC 1.21.1.1 Category:EC 1.21.3 Isopenicillin N synthase EC 1.21.3.1 Tetrahydrocannabinolic acid synthase EC 1.21.3.7 Category:EC 1.21.4 Category:EC 1.21.99 Thyroxine 5-deiodinase EC 1.21.99.3 Iodothyronine deiodinase EC 1.21.99.3 and EC 1.21.99.4

=== Death and legacy === Pauling died of prostate cancer on August 19, 1994, at 19:20 at home in Big Sur, California. He was 93 years old. A grave marker for Pauling was placed in Oswego Pioneer Cemetery in Lake Oswego, Oregon by his sister Pauline, but Pauling's ashes, along with those of his wife, were not buried there until 2005. Pauling's discoveries led to decisive contributions in a diverse array of areas including around 350 publications in the fields of quantum mechanics, inorganic chemistry, organic chemistry, protein structure, molecular biology, and medicine. His work on chemical bonding marks him as one of the founders of modern quantum chemistry. The Nature of the Chemical Bond was the standard work for many years, and concepts like hybridization and electronegativity remain part of standard chemistry textbooks. While his valence bond approach fell short of accounting quantitatively for some of the characteristics of molecules, such as the color of organometallic complexes, and would later be eclipsed by the molecular orbital theory of Robert Mulliken, valence bond theory still competes, in its modern form, with molecular orbital theory and density functional theory (DFT) as a way of describing chemical phenomena. Pauling's work on crystal structure contributed significantly to the prediction and elucidation of the structures of complex minerals and compounds. His discovery of the alpha helix and beta sheet is a fundamental foundation for the study of protein structure. Francis Crick acknowledged Pauling as the "father of molecular biology".

In the early 2000s, 7-Eleven and Dentsu introduced a corporate mascot named Open-Chan (Open 小將), an extraterrestrial dog who wears a rainbow-shaped crown from a fictional planet known as Planet Open to be a "cartoon spokesperson" for the store chain in Taiwan. Open-Chan quickly grew in popularity among Taiwanese children soon after its initial debut. After Open-Chan's subsequent rise to prominence in Taiwan, the character was even introduced in Japan. The unique convenience store culture formed by President Chain Store (7-Eleven in Taiwan) has become a part of Taiwanese culture. 7-Eleven Taiwan also operates an MVNO called ibon mobile, which offers prepaid and postpaid SIM cards using the FarEasTone network.

This site includes an abundance of bedrock mortars, which were used for grinding and crushing of organic materials. Apart from maize, there is evidence of using the mortars for trees, beans, fruits, and animal bones. In regards to chicha, archaeologists believe the workforce at the mortars was predominantly female, considering chicha production is associated with feminine roles. The wide variety of materials used, and the large number of present mortars, demonstrates the location’s important role as a place of mass production. Chicha production sites, like El Shincal, demonstrate the complex production dedicated to preparing for successful and extravagant ceremonial celebrations that revolve around chicha consumption. Additional preparation methods, such as mixing, soaking, or drying, vary plenty depending on the food, and often use a wide variety of vessels to cater to the specific method. Preparation methods will continue to evolve with time as new ways are discovered and adapted with changing availability to resources. Adaptation and flexibility are essential to prioritizing how culinary practices are carried out to best represent the cultural values held by a community.

Sources: en.wikipedia.org

Frequently asked questions

Why are clinical results inconsistent?

Trials differ in patient population, dose schedule, background treatment, and the endpoints used to judge success. Many are small and single-center, so random variation can dominate the reported effects.

In which countries is thymosin alpha 1 approved?

Authorization is limited to a small number of countries and covers specific indications such as chronic hepatitis B and vaccine adjuvant use. Availability and labelling differ by jurisdiction.

How is the peptide characterized in review articles?

Most reviews describe it as an immunomodulatory agent with an uncertain clinical effect. They generally call for larger, better-controlled trials before firm conclusions are drawn.

What is thymosin alpha 1?

It is a 28-amino-acid peptide originally purified from a bovine thymic extract and later produced synthetically. It is studied mainly for its effects on immune cell function.

Network